Target intelligence / Profile preview

Poly(A)-specific ribonuclease PNLDC1 (PNLDC1)

Target
PNLDC1
Molecular classification
Enzyme, Exonuclease, Ribonuclease, Deadenylase
01

Overview

Poly(A)-specific ribonuclease PNLDC1 is a deadenylase enzyme that specifically trims 3′ poly(A) tails from RNA and is structurally related to poly(A)-specific ribonuclease (PARN), but forms a distinct evolutionary group[1]. It is selectively expressed in mammalian embryonic stem cells, testes, and germline cells, where it plays a crucial role in the maturation of piwi-interacting RNAs (piRNAs) by trimming precursor piRNA 3′ ends, thereby enabling transposon silencing and maintaining genome integrity in the germline[1][2][3][4]. PNLDC1 is essential for spermatogenesis, with its loss causing defective piRNA processing and spermatogenic failure leading to male infertility (SPGF57)[2][3][4][5]. The enzyme's activity is tightly regulated via epigenetic mechanisms, is predominantly cytoplasmic (localized to ER), and is involved in pathways controlling cell cycle, chromatin assembly, and reprogramming during early development[1]. Currently, there are no known direct drugs or small molecules that target PNLDC1, nor is it described as a clinically actionable biomarker, but its disruption is a notable cause of genetic azoospermia[5].

Other names
PARN like ribonuclease domain containing exonuclease 1HsPNLDC1FLJ40240dJ195P10.2TrimmerPARN-like domain-containing protein 1Poly(A)-specific ribonuclease domain-containing protein 1SPGF57poly(A)-specific ribonuclease PARN-like domain-containing protein 1
02

Biological functions

piRNA processingSpermatogenesismRNA poly(A) tail shorteningPosttranscriptional regulationGenome surveillanceEpigenetic reprogrammingCell cycle regulationChromatin assembly
03

Disease associations

Spermatogenic failure (SPGF57)Male infertility (azoospermia/oligozoospermia)Other reproductive disorders
04

Safety considerations

Loss-of-function is associated with male infertilitycritical for germline genome integrity and early development, so inhibition may risk fertility and germline mutation[2][3][4][5]

Beyond the preview

Go deeper on Poly(A)-specific ribonuclease PNLDC1 (PNLDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(A)-specific ribonuclease PNLDC1 (PNLDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call